Neurocrine Biosciences Balance Sheet - Annual (NASDAQ:NBIX)

Add to My Stocks
$117.36 $1.12 (0.95%) NBIX stock closing price Sep 17, 2018 (Closing)

A thorough fundamental analysis involves using data from Neurocrine Biosciences balance sheet, apart from other financial statements, to value the business. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Neurocrine Biosciences stock analysis. Annual results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $445.45M and shareholders equity of $372.13M. Neurocrine Biosciences revenue and Neurocrine Biosciences operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Neurocrine Biosciences financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Marketable Securities261.21M224.08M304.99M162.79M100.95M109.25M78.99M72.81M16.13M12M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets7.86M3.09M4.88M4.39M2.7M2.16M1.47M1.71M1.92M-
Total Current Assets
Property Plant & Equipment38.39M32.22M30.29M31.25M30.1M36.22M36.47M38.08M40.02M45.15M
Accumulated Depreciation27.58M25.95M26.86M28.74M28.33M34.32M34.88M36.55M37.33M38.96M
Net Property Plant & Equipment
Investment & Advances247.36M43.49M82.48M37.49M---3.73M6.41M21.05M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets4.5M4.88M4.79M4.83M4.44M4.33M4.3M6.1M6.32M9.51M
Total Assets
Notes Payable----------
Accounts Payable53.52M5.08M2.56M---1.11M-2.18M1.59M
Current Portion Long-Term Debt----------
Current Portion Capital Leases-------3.38M4.28M7.87M
Accrued Expenses-21.09M19.03M11.5M7.95M8.09M8.45M8.6M6.24M10.9M
Income Taxes Payable----------
Other Current Liabilities-3.52M3.69M3.44M3.22M6.05M37.28M39.97M7.24M5.72M
Total Current Liabilities
Deferred Taxes/Income18.27M17.6M21.12M14.32M17.64M20.87M26.92M64.2M38.75M44.54M
Convertible Debt----------
Long-Term Debt369.61M---------
Non-Current Capital Leases--1.55M2.21M2.68M3.09M2.32M6.58M7.24M7.52M
Other Long-Term Liabilities3.13M1.57M1.93M2.13M2.24M1.99M1.92M1.51M-3.24M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus1.57B1.37B1.34B1.04B886.1M873.98M784.81M781.6M757M741.56M
Retained Earnings-1.2B-1.06B-915.23M-826.3M-765.76M-719.67M-724.69M-762.26M-754.3M-703.26M
Treasury Stock----------
Other Liabilities-1.85M-0.31M-0.97M-0.27M---0.08M-0.04M1.2M-1.57M
Shareholders Equity372.13M314.87M424.45M208.69M120.41M154.37M60.08M19.34M3.95M36.77M
Total Liabilities & Shareholders Equity817.59M365.08M474.78M243.03M154.67M195.97M138.36M144.42M70.81M118.18M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at Neurocrine Biosciences historical stock prices and the current Neurocrine Biosciences stock price can tell you how the stock price has moved, whereas the Neurocrine Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Neurocrine Biosciences company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Neurocrine Biosciences had total assets of $817.59M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. NBIX stock had total liabilities of $445.45M for the year 2017.

Neurocrine Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio